European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication
Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines. ; Fil: Arrossi, Silvina. Centro de Estudios de Estado y Sociedad; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina ; Fil: von Karsa, Lawrence. International Agency for Research on Cancer; Francia ; Fil: Patrick, J. NHS Cancer Screening Programmes Sheffield; Reino Unido. University of Oxford; Reino Unido ; Fil: Segnan, N. International Agency for Research on Cancer; Francia. AO Città della Salute e della Scienza di Torino; Italia ; Fil: Atkin, W. Imperial College London; Reino Unido ; Fil: Halloran, S. University of Surrey; Reino Unido ; Fil: Saito, H. National Cancer Centre; Japón ; Fil: Sauvaget, C. International Agency for Research on Cancer; Francia ; Fil: Scharpantgen, A. Ministry of Health; Luxemburgo ; Fil: Schmiegel, W. Ruhr-Universität Bochum; Alemania ; Fil: Senore, C. AO Città della Salute e della Scienza di Torino; Italia ; Fil: Siddiqi, M. Cancer Foundation of India; India ; Fil: Sighoko, D. University of Chicago; Estados Unidos. Formerly International Agency for Research on Cancer; Francia ; Fil: Smith, R. American Cancer Society; Estados Unidos ; Fil: Smith S. University Hospitals Coventry & Warwickshire NHS Trust; Reino Unido ; Fil: Suchanek, S. Charles University; República Checa ; Fil: Suonio, E. International Agency for Research on Cancer; Francia ; Fil: Tong, W. Chinese Academy of Sciences; República de China ; Fil: Törnberg, S. Stockholm Gotland Regional Cancer Centre. Department of Cancer Screening; Suecia ; Fil: Van Cutsem, E. Katholikie Universiteit Leuven; Bélgica ; Fil: Vignatelli, L. Agenzia Sanitaria e Sociale Regionale; Italia ; Fil: Villain, P. University of Oxford; Reino Unido ; Fil: Voti, L. Formerly International Agency for Research on Cancer; Francia. University of Miami; Estados Unidos ; Fil: Watanabe, H. Niigata University; Japón ; Fil: Watson, J. University of Oxford; Reino Unido ; Fil: Winawer, S. Memorial Sloan–Kettering Cancer Center; Estados Unidos ; Fil: Young, G. Flinders University. Gastrointestinal Services; Australia ; Fil: Zaksas, V. State Patient Fund; Lituania ; Fil: Zappa, M. Cancer Prevention and Research Institute; Italia ; Fil: Valori, R. NHS Endoscopy; Reino Unido